# A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal

> **NCT02317276** · PHASE4 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 11 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** Triamcinolone 0.1%

## Key facts

- **NCT ID:** NCT02317276
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2017-04-06
- **Final completion:** 2017-04-06
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Unable to meet the study's recruitment goals
- **Last updated:** 2019-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02317276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02317276, "A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02317276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*